Best Health Care Grants in American Samoa

The National Institute on Drug Abuse (NIDA) aims to establish a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics. This Center will educate researchers on product development for SUD therapies and provide technical and financial support for initial experiments. It encourages collaboration and outreach to enhance research efforts in drug addiction. Investigators with relevant expertise are invited to consider applying for future opportunities to develop impactful solutions in SUD pharmacotherapeutics.

The National Institute of Dental and Craniofacial Research (NIDCR) is set to announce a funding opportunity for clinical trials and observational studies within its Dental Primary Care Practice-Based Research Network (PBRN). This initiative aims to enhance the integration of oral and medical health by facilitating research conducted in dental practices. While applications are not currently being accepted, this notice serves to encourage collaborations that will lead to impactful projects in whole-person health.

The Microplastics Research and Resource Coordination Center aims to foster collaboration among researchers in biomedical and material sciences to understand the health impacts of micro/nanoplastics (M/NPs). This initiative will enhance research reliability by standardizing sampling, analytical practices, and data harmonization. The center will lead efforts in best practices and provide essential guidance to the M/NPs research community, ultimately advancing knowledge and methodologies in this critical area of study.

The Autism Centers of Excellence (ACE) initiative, spearheaded by the Eunice Kennedy Shriver National Institute for Child Health and Human Development along with several other prominent institutes, aims to encourage innovative research projects. While applications are not currently open, potential applicants are urged to prepare collaborative proposals that leverage cutting-edge technologies. This funding opportunity, utilizing the P50 Research Program Projects and Centers activity code, seeks to build upon over two decades of research advancements.

The Autism Centers of Excellence R01 aims to advance research in autism through collaborative networks, enhancing the past 23 years of progress. This initiative encourages innovative methods and technologies, inviting experts to consider applying for future funding opportunities. Although applications are not currently solicited, potential applicants are urged to form meaningful collaborations. This funding opportunity reflects a commitment to improving research in autism, leveraging diverse scientific expertise to address critical challenges in the field.

The National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32) aims to cultivate a diverse array of skilled scientists to meet the biomedical research challenges of the nation. This program supports U.S. institutions in developing evidence-based biomedical graduate training and mentoring approaches. By integrating didactic, research, and career development components, it prepares trainees for impactful careers addressing critical health-related research needs.

The ASH Visitor Training Program (VTP) aims to enhance hematology expertise in low- and middle-income countries by funding hematologists for up to 12 weeks of specialized training. Participants work under the mentorship of an ASH member to tackle specific hematological challenges in their home institutions. This program is open to professionals at any career stage, except trainees, and does not require ASH membership. A host mentor is essential for application.

The Cancer Research Education Grants Program (R25) aims to enhance research education in areas crucial to the NIH mission. This program supports innovative courses that develop skills in cancer research, covering topics such as prevention, diagnosis, and treatment. Grant applications are encouraged to be creative and state-of-the-art, addressing the needs of patients and their families. Key deadlines for applications span from January 2024 to September 2026, ensuring ongoing support for educational initiatives.

Lockheed Martin is funding PLTW grants to schools for adding or expanding PLTW Engineering programs. This initiative aims to meet the growing need for engineers and technology professionals by providing students with essential skills in engineering and computer science. Since 2007, over 300 PLTW programs have been launched, benefiting more than 77,000 students nationwide. Schools can apply for funding to either start new programs or enhance existing ones, promoting innovation in education.

The PLTW Computer Science grant, funded by Lockheed Martin, aims to support schools in expanding or establishing PLTW Computer Science courses. This initiative addresses the critical shortage of skilled professionals in STEM fields, enabling students to gain essential knowledge and skills. Since 2007, Lockheed Martin has successfully partnered with PLTW to implement programs across the nation, impacting over 77,000 students. Schools are encouraged to apply for funding to enhance their computer science curriculum.

The Diaper Distribution Demonstration Research Pilot (DDDRP), funded by the US Dept. of Health & Human Services, aims to provide essential diaper supplies to low-income families. With $29 million available, the program will evaluate partnerships between community organizations to enhance diaper distribution and improve family health and economic stability. Activities include training, bulk purchasing, and referrals to supportive services, ensuring families receive the resources they need for a better quality of life.

The NIH Instrumentation Grant Program for Resource-Limited Institutions supports the acquisition of advanced scientific instruments. This initiative aims to bolster biomedical research capabilities and educational opportunities at institutions that typically receive limited NIH Research Project Grant funding. By facilitating access to modern technology, the program enhances research quality and fosters innovation in healthcare and related fields.

The HEAL Initiative aims to address the significant overlap between chronic pain (CP) and opioid use disorder (OUD), with 40-75% of individuals affected by both. The IMPOWR project focuses on testing innovative interventions and implementation strategies to integrate care for CP and OUD across various health systems. The BEACON Center will enhance network coordination, build capacity, and develop resources to address barriers in service delivery, ultimately improving sustainability and scalability of evidence-based practices.

The Health and Health Care Disparities grant aims to support innovative research that addresses the health challenges faced by individuals with disabilities, particularly in communities experiencing health disparities. Key application deadlines span from February 2024 to October 2026. This funding opportunity invites research proposals that explore the underlying factors affecting the health and well-being of these populations, promoting interventions that can lead to significant improvements in health equity.

The Cancer Health Equity Research Centers (CHERCs) initiative by the American Cancer Society aims to address health disparities by supporting research focused on social determinants affecting cancer care. This program encourages innovative projects that engage communities, enhance access, and improve outcomes across diverse populations. By fostering collaborations and promoting multidisciplinary approaches, CHERCs strive to create equitable cancer prevention and treatment solutions, ensuring that all individuals have fair opportunities for cancer care and survivorship.

The Institutional Research Grants (IRG) program by the American Cancer Society provides essential seed funding for newly independent investigators to launch cancer research projects. Aimed at junior faculty, these grants offer $120,000 annually for three years, supporting the development of preliminary results necessary for competing for larger national grants. Eligible applicants must be at US academic institutions and hold the rank of Associate or Full Professor, with a proven track record in research and mentorship.

The American Cancer Society (ACS) and the American Society for Radiation Oncology (ASTRO) co-fund the Clinician Scientist Development Grant (CSDG), aimed at advancing the research careers of clinician scientists in radiation oncology. Eligible applicants are full-time faculty members at U.S. institutions with a doctoral degree and an active clinical license. The grant supports research for 3 to 5 years, providing $135,000 annually for direct costs, plus allowable indirect costs, while encouraging diversity in applications.

The Clinician Scientist Development Grant (CSDG) by the American Cancer Society supports full-time faculty aiming to become independent clinician scientists while maintaining clinical practice. Eligible applicants must hold a doctoral degree, an active clinical license, and have clinical care experience. The grant provides funding of $135,000 annually for 3 to 5 years, including allowable indirect costs, to advance cancer research in key priority areas.

The Child Protection Compact Annual Program Statement invites proposals aimed at combating child trafficking through collaborative efforts between the United States and other countries. This initiative focuses on enhancing the capacity to prosecute traffickers, providing care for victims, and implementing preventive measures. Organizations interested in applying must align with the objectives of the CPC to ensure comprehensive support and effective intervention against all forms of child trafficking.

The TIP Office of the US Department of State invites applications for projects aimed at combating human trafficking, adhering to the Trafficking Victims Protection Act. This initiative prioritizes prosecuting traffickers, protecting victims, and preventing trafficking through strategies outlined in the National Security Strategy, executive orders, and the annual Trafficking in Persons Report, while aligning with America First Foreign Policy priorities.

The DoW Neurofibromatosis Research Academy – Leadership Award supports established neurofibromatosis investigators to lead a virtual research academy. Designed for early-career scholars, this award promotes mentorship and collaboration in neurofibromatosis research. The Academy Director and Deputy Director, both at the Associate Professor level, will oversee pilot research projects that engage scholars and their mentors, fostering a dynamic research environment. This initiative aims to enhance the future of neurofibromatosis research through innovative leadership and collaboration.

The FY26 Hearing Restoration Research Program (HRRP) Focused Research Award (FRA) aims to enhance drug discovery and therapeutic development for hearing restoration following military-related auditory injuries. The award supports preclinical and clinical studies aligned with HRRP focus areas. It features two funding levels, including a Partnering Principal Investigator option, and evaluates proposals based on research rationale, strategy, impact, and personnel. Notably, it excludes funding for clinical trials, tinnitus, and vestibular research.

The FY 2027 International Visitor Leadership Program (IVLP) invites proposals for cooperative agreements to support staff and overhead costs for National Program Agencies. This foundational exchange program enhances U.S. foreign policy by fostering relationships with global leaders. Eligible recipients should have foreign policy expertise and experience in professional exchanges, creating tailored visits that align with participants' interests and U.S. goals. This initiative continues a legacy of impactful international collaboration since 1940.

The DOW Combat Readiness – Medical Research Program's FY26 Translational Research Award supports innovative research aimed at improving trauma care outcomes. This program emphasizes hypothesis-driven studies that can transition promising technologies into practical solutions for enhancing casualty survivability. Applicants must provide preliminary data and utilize validated animal models, with a focus on projects that meet a minimum technology readiness level of 4, ensuring a mature translational research effort.

The National Institute of Allergy and Infectious Diseases (NIAID) is funding research to enhance drug susceptibility testing (DST) for mycobacteria. This initiative aims to improve testing for tuberculosis (TB) and non-tuberculous mycobacterial (NTM) infections, which are on the rise. Current methods are slow and ineffective against drug-resistant strains, making rapid DSTs essential for effective treatment and reducing transmission rates. Innovative approaches, including rapid genotypic and phenotypic methods, will be supported to address these challenges.

The Childhood Asthma in Urban Settings Clinical Research Network (CAUSE) aims to enhance asthma prevention and treatment in economically disadvantaged pediatric populations. Funded by the NIH, CAUSE supports multi-site clinical studies to identify innovative strategies and treatment targets for asthma. Utilizing systems biology, the network seeks to discover specific disease endotypes suitable for new therapeutic approaches, addressing the high burden of asthma in urban settings.